상부 호흡기 상피세포주 AMC-HN-4, AMC-HN-7, AMC-HN-8에서 Chlamydia Pneumoniae의 배양 효율 = Efficiency of Chlamydia Pneumoniae Culturein the Upper Airway Epithelial Cell Lines: AMC-HN-4, AMC-HN-7, and AMC-HN-8

다국어 초록 (Multilingual Abstract)

Background and Objectives Chlamydia pneumoniae (C. pneumoniae) is a well-known pathogen of upper and lower respiratory tract infection. For a more efficient and practical cell culture system, we studied the growth of two clinical isolates of C. pneumoniae in selected cell lines derived from the human respiratory tract.
Materials and Method HeLa 229, HEp-2, which are well-known cell lines for the culture of C. pneumoniae, and AMC-HN-4, AMC-HN-7, AMC-HN-8, which are the newly developed cell lines in Korea were examined. Strains of C. pneumoniae used in this study were TW-183 and LKK-1 (the first Korean strain). Chlamydia was inoculated on each confluent cell line and incubated for 48 hrs. After staining with anti-Chlamydial lipopolysaccharide monoclonal antibody, we compared the efficiency of the C. pneumoniae infection on each cell line by counting the inclusion bodies.
Results In culturing C. pneumoniae LKK-1, AMC-HN-4 cells consistently yielded higher inclusion body counts than HeLa 229 cells did, whereas inclusion body counts by AMC-HN-7 cells was low. AMC-HN-7, AMC HN-8 cells yielded lower inclusion body counts than HEp-2 cells. In culturing C. pneumoniae TW-183, AMC-HN-4, AMC-HN-7, and AMC-HN-8 cells did not yield lower inclusion body counts than HeLa 229 cells did. AMC-HN-7 cells yielded lower inclusion body counts than HEp-2 cells.
Conclusion The newly established upper airway epithelial cell lines, AMC HN-4 and AMC HN-8, had similar culture efficiency as HeLa 229 and HEp-2 cells for Chlamydial infection; therefore, these two cell lines could be used for the future studies of C. pneumoniae.

참고문헌 (Reference)

1 Chen TR, "Re-evaluation of HeLa, HeLa S3, and HEp-2 karyotypes" 48 (48): 19-24, 1988

2 Ikezawa S, "Prevalence of Chlamydia pneumoniae in acute respiratory tract infection and detection of anti-Chlamydia pneumoniae-specific IgE in Japanese children with reactive airway disease" 48 (48): 165-170, 2001

3 Pruckler JM, "Optimizing culture of Chlamydia pneumoniae by using multiple centrifugations" 37 (37): 3399-3401, 1999

4 Kumamoto Y, "Method for in vitro determination of chlamydial susceptiblity to antimicrobial agents" 40 (40): 308-314, 1992

5 Jahn HU, "Infection and activation of airway epithelial cells by Chlamydia pneumoniae" 182 (182): 1678-1687, 2000

6 Yang J, "Induction of proinflammatory cytokines in human lung epithelial cells during Chlamydia pneumoniae infection" 71 (71): 614-620, 2003

7 Li D, "Highyield culture and purification of Chlamydiaceae bacteria" 61 (61): 17-24, 2005

8 Kim SY, "Establishment and characterization of nine new head and neck cancer cell lines" 117 (117): 775-784, 1997

9 Wong KH, "Efficient culture of Chlamydia pneumoniae with cell lines derived from the human respiratory tract" 30 (30): 1625-1630, 1992

10 Choi TY, "Detection of Chlamydia pneumoniae by ‘Touchdown’ PCR" 18 (18): 570-576, 1998

11 Woodhead M, "Community acquired pneumonia in elderly people. Addition of erythromycin is not currently justified" 317 (317): 1524-, 1998

12 Blasi F, "Chlamydophila pneumoniae" 15 (15): 29-35, 2009

13 Blasi F, "Chlamydia pneumoniae respiratory infections" 13 (13): 161-164, 2000

14 Peeling RW, "Chlamydia pneumoniae infections: applications of laboratory methods, In Chlamydia pneumoniae: the lung and the heart. 1st ed" Springer 33-42, 1999

15 Block SL, "Chlamydia pneumoniae in acute otitis media" 16 (16): 858-862, 1997

16 Lee SJ, "Characterization of the first Korean isolate of a Chlamydia pneumoniae strain" 56 (56): 62-64, 2003

17 Lee SJ, "Atypical pathogens in adult patients admitted with community-acquired pneumonia in Korea" 55 (55): 157-159, 2002

18 Dal Molin G, "A population based seroepidemiological survey of Chlamydia pneumoniae infections in schoolchildren" 58 (58): 617-620, 2005

19 Kazuyama Y, "A novel method for isolation of Chlamydia pneumoniae by treatment with trypsin or EDTA" 35 (35): 1624-1626, 1997

20 Grayston JT, "A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections" 315 (315): 161-168, 1986